OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001567892

Keenova Therapeutics plc

Keenova Therapeutics plc (CIK 0001567892, EIN 98-1088325) reported revenue of $1.43 billion ($1,430,600,000) for FY2025 (2024-12-28 to 2025-12-31) and net income of -$489.5 million (-$489,500,000) for FY2025 (2024-12-28 to 2025-12-31), as filed in its 10-K filed 2026-04-15 (accession 0001628280-26-025238).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001567892
EIN98-1088325
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationL2
Fiscal year endDecember 31
Filer categoryNon-accelerated filer
Entity typeoperating
Olympus entity IDorg_636wwpb8ncref5yh0ppxdf6fzy
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$1,430,600,000FY20252024-12-28 to 2025-12-3110-K2026-04-150001628280-26-025238RevenueFromContractWithCustomerIncludingAssessedTax
Net income-$489,500,000FY20252024-12-28 to 2025-12-3110-K2026-04-150001628280-26-025238NetIncomeLoss
Total assets$5,628,600,000FY2025as of 2025-12-3110-K2026-04-150001628280-26-025238Assets
Total liabilities$3,563,400,000FY2025as of 2025-12-3110-K2026-04-150001628280-26-025238Liabilities
Stockholders' equity$2,065,200,000FY2025as of 2025-12-3110-K2026-04-150001628280-26-025238StockholdersEquity
Operating cash flow$125,000,000FY20252024-12-28 to 2025-12-3110-K2026-04-150001628280-26-025238NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Diluted earnings per share-$17.5 per shareFY20252024-12-28 to 2025-12-3110-K2026-04-150001628280-26-025238EarningsPerShareDiluted
Shares outstanding39,581,987 sharesFY2025as of 2026-04-0810-K2026-04-150001628280-26-025238EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2016-2025, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20252024-12-28 to 2025-12-31$1,430,600,00010-K2026-04-150001628280-26-025238
RevenueFY20242023-12-30 to 2024-12-27$1,083,400,00010-K2026-04-150001628280-26-025238
RevenueFY20212020-12-26 to 2021-12-31$2,208,800,00010-K2024-03-260001567892-24-000008
RevenueFY20202019-12-28 to 2020-12-25$2,213,400,00010-K2023-03-030001567892-23-000014
RevenueFY20192018-12-29 to 2019-12-27$3,162,500,00010-K2022-03-150001567892-22-000007
RevenueFY20182017-12-30 to 2018-12-28$3,215,600,00010-K2021-03-100001567892-21-000011
RevenueFY20172016-12-31 to 2017-12-29$3,221,600,00010-K2020-02-260001567892-20-000005
RevenueFY20162015-09-26 to 2016-09-30$3,380,800,00010-K2019-02-260001567892-19-000009
Net incomeFY20252024-12-28 to 2025-12-31-$489,500,00010-K2026-04-150001628280-26-025238
Net incomeFY20242023-12-30 to 2024-12-27$477,900,00010-K2026-04-150001628280-26-025238
Net incomeFY20212020-12-26 to 2021-12-31-$717,400,00010-K2024-03-260001567892-24-000008
Net incomeFY20202019-12-28 to 2020-12-25-$944,600,00010-K2023-03-030001567892-23-000014
Net incomeFY20192018-12-29 to 2019-12-27-$996,500,00010-K2022-03-150001567892-22-000007
Net incomeFY20182017-12-30 to 2018-12-28-$3,607,000,00010-K2021-03-100001567892-21-000011
Net incomeFY20172016-12-31 to 2017-12-29$2,134,400,00010-K2020-02-260001567892-20-000005
Net incomeFY20162015-09-26 to 2016-09-30$643,700,00010-K2019-02-260001567892-19-000009
  • Revenue for FY2024 was restated: first reported as $1,979,700,000 (accession 0001567892-25-000010, filed 2025-03-13).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2026-08-112026-06-300001628280-26-055614mnk-20260630.htm
10-Q2026-05-122026-03-310001628280-26-034209mnk-20260331.htm
10-K2026-04-152025-12-310001628280-26-025238mnk-20251231.htm
10-Q2025-11-102025-09-260001628280-25-051167mnk-20250926.htm
10-Q2025-08-062025-06-270001567892-25-000040mnk-20250627.htm
10-Q2025-05-122025-03-280001567892-25-000024mnk-20250328.htm
10-K2025-03-132024-12-270001567892-25-000010mnk-20241227.htm
10-Q2024-11-052024-09-270001567892-24-000041mnk-20240927.htm
10-Q2024-08-062024-06-280001567892-24-000030mnk-20240628.htm
10-Q2024-05-092024-03-290001567892-24-000017mnk-20240329.htm
10-K2024-03-262023-12-290001567892-24-000008mnk-20231229.htm
10-Q2023-11-072023-09-290001567892-23-000041mnk-20230929.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001567892published by the sourcedata.sec.gov/submissions/CIK0001567892.json2026-10-21
Employer Identification Number (EIN) · US-EIN98-1088325published by the sourcedata.sec.gov/submissions/CIK0001567892.json2026-10-21

Former names

NameFromTo
Mallinckrodt plc2013-02-012025-11-10

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001567892.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001567892.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001567892" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001567892/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001567892/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1567892"}

On SEC EDGAR

About this data